Administrative Core
Administrative Core
批准号:
9151285
负责人:
Michael S Gilmore
金额:
$15.71万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-01 至 2021-08-31
关键词:
AnabolismAntibiotic ResistanceBiochemistryBiologyCell WallCenter for Translational Science ActivitiesClinical SciencesClinical TreatmentCommunicationCommunitiesComplementComplexDevelopmentEarEnterococcusEyeFacultyFosteringGeneral HospitalsGenus staphylococcusGoalsIndividualInfectionKnowledgeMassachusettsModelingMolecular BiologyMulti-Drug ResistanceNational Institute of Allergy and Infectious DiseaseParticipantPathogenesisPreventionResearch InfrastructureResistanceResourcesScienceScientistSumSystemTechnologyToxic effectUniversitiescatalystdata sharingdesignexperienceimplementation researchinhibitor/antagonistmedical schoolsmethicillin resistant Staphylococcus aureusmicrobialmulti-drug resistant pathogenmultidisciplinarynext generationnovelnovel strategiespathogenpreventprogramsscreeningsuccesstool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
SUMMARY
This Harvard-wide Program on Antibiotic Resistance (HPAR) proposal outlines the design and function of a
novel, multidisciplinary, collaborative partnership to develop new approaches for treating and preventing
multidrug resistant MRSA and VRE infection. Although discovery and delivery of novel and promising new
compounds to the development pipeline is a major overall goal, because this is an academic effort, we also will
add to the scientific knowledge that underpins the novel inhibitors developed; add to the understanding of
resistance; and develop novel new tools for studying host-pathogen interactions and multidrug resistant
pathogens. This project is being proposed by an accomplished group of scientists with extensive experience in
the biochemistry of cell wall biosynthesis and use of that information to design screens and new inhibitors; the
molecular biology of model host systems and the use of those systems in novel ways for screening compounds
that hit complex targets with minimal toxicity; the development and application of high throughput next
generation technologies; and the pathogenesis, biology and clinical treatment of infection caused by multidrug
resistant staphylococci and enterococci. This scientific expertise is complemented by substantial administrative
experience. The goal of the HPAR Administrative Core therefore is to oversee the smooth implementation of
the research plan and deployment of resources, and to foster the cohesive and well functioning whole to
achieve goals that are greater than the sum of the individual projects. This will be accomplished by achieving
the following Specific Aims: 1) Provide program management, oversight, and compliance assurance, 2)
Facilitate interactions between participants from the various components of the Harvard Medical School
(including faculty located on the Longwood Campus, at Massachusetts General Hospital, and the
Massachusetts Eye and Ear Infirmary), and the Mylonakis lab now in part at Brown University – in a smooth
and effective manner; 3) Provide critical infrastructure for fiscal management of the program; 4) Provide
connectivity to and leverage other Harvard-wide initiatives, including the Microbial Sciences Initiative (MSI),
and Catalyst Clinical and Translational Sciences Center; and 5) Provide a single point of contact and active
coordination for on-going communication with NIAID, the Program Officer, and other NIAID staff and initiatives.
The Administrative Core has managed the previous period in a way that led to a highly functioning, well
integrated, and synergistic whole, and achieved additional aims generating resources and fostering data
sharing with the greater scientific community. The proposed continuation period will build on these successes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Role of Enterococcus Unique Hypothetical EF1909 in Intrinsic β-lactam Resistance
-
批准号:10569041
-
项目类别:
-
资助金额:$21.25万
-
财政年份:2022
-
负责人:Michael S Gilmore
-
依托单位:
The Role of Enterococcus Unique Hypothetical EF1909 in Intrinsic β-lactam Resistance
-
批准号:10464409
-
项目类别:
-
资助金额:$25.3万
-
财政年份:2022
-
负责人:Michael S Gilmore
-
依托单位:
Determinants of Ocular Surface Biogeography
-
批准号:10396467
-
项目类别:
-
资助金额:$41.23万
-
财政年份:2020
-
负责人:Michael S Gilmore
-
依托单位:
Determinants of Ocular Surface Biogeography
-
批准号:10596574
-
项目类别:
-
资助金额:$42.5万
-
财政年份:2020
-
负责人:Michael S Gilmore
-
依托单位:
New understanding of LTA as a determinant of daptomycin susceptibility in VRE E. faecium
-
批准号:9926227
-
项目类别:
-
资助金额:$21.25万
-
财政年份:2019
-
负责人:Michael S Gilmore
-
依托单位:
New understanding of LTA as a determinant of daptomycin susceptibility in VRE E. faecium
-
批准号:9810471
-
项目类别:
-
资助金额:$25.5万
-
财政年份:2019
-
负责人:Michael S Gilmore
-
依托单位:
Subproject 3 New Approaches to Treatment and Prevention of Antibiotic Resistant Infection
-
批准号:9151288
-
项目类别:
-
资助金额:$33.84万
-
财政年份:2016
-
负责人:Michael S Gilmore
-
依托单位:
Molecular Basis for Ocular Surface Tropism in Conjunctivitis
-
批准号:9264533
-
项目类别:
-
资助金额:$41.0万
-
财政年份:2014
-
负责人:Michael S Gilmore
-
依托单位:
Molecular Basis for Ocular Surface Tropism in Conjunctivitis
-
批准号:8670576
-
项目类别:
-
资助金额:$41.0万
-
财政年份:2014
-
负责人:Michael S Gilmore
-
依托单位:
Identification of infection-critical S. aureus traits by TnSeq
-
批准号:8660637
-
项目类别:
-
资助金额:$20.5万
-
财政年份:2013
-
负责人:Michael S Gilmore
-
依托单位:
Enterococcal Pathogenesis:Role of Cytolysin
-
批准号:9322594
-
项目类别:
-
资助金额:$41.0万
-
财政年份:2013
-
负责人:Michael S Gilmore
-
依托单位:
Enterococcal Pathogenesis:Role of Cytolysin
-
批准号:8611481
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2013
-
负责人:Michael S Gilmore
-
依托单位:
Enterococcal Pathogenesis:Role of Cytolysin
-
批准号:9117371
-
项目类别:
-
资助金额:$41.0万
-
财政年份:2013
-
负责人:Michael S Gilmore
-
依托单位:
Identification of infection-critical S. aureus traits by TnSeq
-
批准号:8564610
-
项目类别:
-
资助金额:$23.01万
-
财政年份:2013
-
负责人:Michael S Gilmore
-
依托单位:
Modeling CRISPR to Preserve Antibiotics
-
批准号:8642660
-
项目类别:
-
资助金额:$18.45万
-
财政年份:2013
-
负责人:Michael S Gilmore
-
依托单位:
Modeling CRISPR to Preserve Antibiotics
-
批准号:8503236
-
项目类别:
-
资助金额:$22.01万
-
财政年份:2013
-
负责人:Michael S Gilmore
-
依托单位:
Targeting and Containing the Spread of VRSA
-
批准号:8376874
-
项目类别:
-
资助金额:$29.15万
-
财政年份:2012
-
负责人:Michael S Gilmore
-
依托单位:
Adminstrative Core
-
批准号:8376878
-
项目类别:
-
资助金额:$16.86万
-
财政年份:2012
-
负责人:Michael S Gilmore
-
依托单位:
2011 Microbial Adhesion & Signal Transduction Gordon Research Conference
-
批准号:8118646
-
项目类别:
-
资助金额:$1.2万
-
财政年份:2011
-
负责人:Michael S Gilmore
-
依托单位:
Targeting and Containing the Spread of VRSA
-
批准号:8202949
-
项目类别:
-
资助金额:$29.12万
-
财政年份:2011
-
负责人:Michael S Gilmore
-
依托单位:
海外基金